Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Clinical guidelines

Addressing comorbidities in systemic inflammatory disorders

Nature Reviews Rheumatology volume 11, pages 689–691 (2015)Cite this article

Subjects

Comorbidities affect outcomes and treatment decisions in patients with immune-driven systemic inflammatory disorders. New recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis and psoriatic arthritis might help optimize the management of these diseases and improve patient outcomes, but several considerations are relevant to their clinical implementation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Boyd, T. & Kavanaugh, A. Novel treatment concepts in psoriatic arthritis. Rheum. Dis. Clin. N. Amer. (in press).

  2. Roubille, C. et al. Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative. J. Rheumatol. http://dx.doi.org/10.3899/jrheum.141112.

  3. Kavanaugh, A. Rheumatoid arthritis: guidelines for RA therapy—avoiding hamartia. Nat. Rev. Rheumatol. 6, 505–506 (2010).

    Article  Google Scholar 

  4. Singh, J. A. et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. (Hoboken) 64, 625–639 (2012).

    Article  CAS  Google Scholar 

  5. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73, 492–509 (2014).

    Article  CAS  Google Scholar 

  6. Dougados, M. et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann. Rheum. Dis. 73, 62–68 (2014).

    Article  Google Scholar 

  7. Armstrong, A. W. et al. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology 225, 121–126 (2012).

    Article  Google Scholar 

  8. Ogdie, A. et al. Recognizing and managing comorbidities in psoriatic arthritis. Curr. Opin. Rheumatol. 27, 118–126 (2015).

    Article  Google Scholar 

  9. Radner, H. et al. The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/kev239.

  10. Di Minno, M. N. et al. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann. Rheum. Dis. 73, 1157–1162 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Western University, Schulich School of Medicine & Dentistry, St Joseph's Health Care, 268 Grosvenor Street, London, N6A 4V2, ON, Canada

    Tristan Boyd

  2. Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, School of Medicine, 9500 Gilman Drive, MC 0943, La Jolla, 92093-0942, CA, USA

    Arthur Kavanaugh

Authors
  1. Tristan Boyd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arthur Kavanaugh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur Kavanaugh.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boyd, T., Kavanaugh, A. Addressing comorbidities in systemic inflammatory disorders. Nat Rev Rheumatol 11, 689–691 (2015). https://doi.org/10.1038/nrrheum.2015.129

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2015.129

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer